Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Cameron

Showing results (851-860 of 865) with videos related to

Pageof 87
Sort By:
Cancer Discovery|October 12, 2022
Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired ResistanceJunhua Lyu, Yuxuan Liu, Lihu Gong, et al.
Biorxiv : the Preprint Server for Biology|October 3, 2025
Atlas of Lysosomal Aging Reveals a Molecular Clock of Storage Disorder-Associated MetabolitesAnna M Puszynska, Thao P Nguyen, Andrew L Cangelosi, et al.
Neurology|August 4, 2025
Anticoagulation Strategies Following Breakthrough Ischemic Stroke While on Direct Anticoagulants: A Meta-AnalysisMichele Romoli, Maurizio Paciaroni, Nicola Marrone, et al.
Circulation|March 24, 2025
Hypertension and Atrial Fibrillation: A Frontier Review From the AF-SCREEN International CollaborationTeemu J Niiranen, Renate B Schnabel, Aletta E Schutte, et al.
Biorxiv : the Preprint Server for Biology|September 15, 2025
Reprogramming Factors Activate a Non-Canonical Oxidative Resilience Pathway That Can Rejuvenate RPEs and Restore VisionYuancheng Ryan Lu, James C Cameron, Yan Hu, et al.
Blood Advances|March 20, 2020
Genomic profiles and clinical outcomes of de novo blastoid/pleomorphic MCL are distinct from those of transformed MCLPreetesh Jain, Shaojun Zhang, Rashmi Kanagal-Shamanna, et al.
American Journal of Hematology|April 3, 2020
Efficacy of venetoclax in high risk relapsed mantle cell lymphoma (MCL) - outcomes and mutation profile from venetoclax resistant MCL patientsShuangtao Zhao, Rashmi Kanagal-Shamanna, Lucy Navsaria, et al.
The Lancet. Oncology|January 25, 2022
Ibrutinib-rituximab followed by R-HCVAD as frontline treatment for young patients (≤65 years) with mantle cell lymphoma (WINDOW-1): a single-arm, phase 2 trialMichael L Wang, Preetesh Jain, Shuangtao Zhao, et al.
The Journal of Infection|December 3, 2025
Reactogenicity and immunogenicity following heterologous and homologous third dose COVID-19 vaccination in UK adolescents (Com-COV3): A randomised controlled non-inferiority trialE Kelly, M Greenland, P de Whalley, et al.
Scientific Data|November 5, 2024
Historical dataset details the distribution, extent and form of lost Ostrea edulis reef ecosystemsRuth H Thurstan, Hannah McCormick, Joanne Preston, et al.
Pageof 87

Showing results (851-860 of 865) with videos related to

Sort By:
Pageof 87
Cancer Discovery|October 12, 2022
Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired ResistanceJunhua Lyu, Yuxuan Liu, Lihu Gong, et al.
Biorxiv : the Preprint Server for Biology|October 3, 2025
Atlas of Lysosomal Aging Reveals a Molecular Clock of Storage Disorder-Associated MetabolitesAnna M Puszynska, Thao P Nguyen, Andrew L Cangelosi, et al.
Neurology|August 4, 2025
Anticoagulation Strategies Following Breakthrough Ischemic Stroke While on Direct Anticoagulants: A Meta-AnalysisMichele Romoli, Maurizio Paciaroni, Nicola Marrone, et al.
Circulation|March 24, 2025
Hypertension and Atrial Fibrillation: A Frontier Review From the AF-SCREEN International CollaborationTeemu J Niiranen, Renate B Schnabel, Aletta E Schutte, et al.
Biorxiv : the Preprint Server for Biology|September 15, 2025
Reprogramming Factors Activate a Non-Canonical Oxidative Resilience Pathway That Can Rejuvenate RPEs and Restore VisionYuancheng Ryan Lu, James C Cameron, Yan Hu, et al.
Blood Advances|March 20, 2020
Genomic profiles and clinical outcomes of de novo blastoid/pleomorphic MCL are distinct from those of transformed MCLPreetesh Jain, Shaojun Zhang, Rashmi Kanagal-Shamanna, et al.
American Journal of Hematology|April 3, 2020
Efficacy of venetoclax in high risk relapsed mantle cell lymphoma (MCL) - outcomes and mutation profile from venetoclax resistant MCL patientsShuangtao Zhao, Rashmi Kanagal-Shamanna, Lucy Navsaria, et al.
The Lancet. Oncology|January 25, 2022
Ibrutinib-rituximab followed by R-HCVAD as frontline treatment for young patients (≤65 years) with mantle cell lymphoma (WINDOW-1): a single-arm, phase 2 trialMichael L Wang, Preetesh Jain, Shuangtao Zhao, et al.
The Journal of Infection|December 3, 2025
Reactogenicity and immunogenicity following heterologous and homologous third dose COVID-19 vaccination in UK adolescents (Com-COV3): A randomised controlled non-inferiority trialE Kelly, M Greenland, P de Whalley, et al.
Scientific Data|November 5, 2024
Historical dataset details the distribution, extent and form of lost Ostrea edulis reef ecosystemsRuth H Thurstan, Hannah McCormick, Joanne Preston, et al.
Pageof 87